Loading…
Based on limited metadata, the FDA issued a Warning Letter to Ibitta Enterprises, Inc. on September 27, 2019, regarding their dietary supplement products. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The letter falls under FDA's dietary supplement regulatory authority, though the specific issuing office and violation count are not documented in this metadata summary.